NVQ
2 FDA 510(k) clearances · Product code
FDA profile
- Official device name
- Bacteriophage And Controls, B. Anthracis Lysis
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.3045
- Medical specialty
- Microbiology
- FDA definition
- A gamma phage lysis assay intended for the identification of bacillus anthracis from non-hemolytic, aerobic gram positive colonies isolated from sheep blood agar. To aid in the laboratory identification of bacillus anthracis culture growth by lysis with a specific bacteriophage.
Download CSV table Client report (share link) ◉ Watch
Both buttons carry the same predicate table: the CSV downloads for your worksheet, the report is a shareable page for clients. Exports: 3 free/month with an account · reports & watching free.
Building a predicate table? Click + Add on candidates below (up to 8), then compare and export from your Builder.
| Record | Firm | Date | Builder |
|---|---|---|---|
| GAMMA PHAGE LYSIS ASSAY FOR THE IDENTIFICATION OF BACILLUS ANTHRAC (K143592) | The Surgeon General, Department of the Army | 2015-04-16 | + Add |
| GAMMA PHAGE LYSIS ASSAY FOR THE IDENTIFICATION OF BACILLUS ANTHRACIS (K051794) | Office of the Surgeon General, U.S. Army | 2005-08-16 | + Add |
Track NVQ automatically
Every clearance here is in the API, with alerts when new ones post.